Serologicals to Acquire Ion Channel Cell Line Provider Cytomyx

Mar 14, 2006

NEW YORK, March 14 (GenomeWeb News) - Serologicals will acquire Cytomyx, a wholly owned subsidiary of Cytomyx Holdings, Serologicals said today.

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.